These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3280873)

  • 1. Specificity of the cannabinoid metabolite and phencyclidine EMIT d.a.u. assays.
    Allen LV; Stiles ML
    J Anal Toxicol; 1988; 12(1):45-7. PubMed ID: 3280873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discussion of EMIT d.a.u. assays.
    Gorsky JE
    J Anal Toxicol; 1988; 12(5):300. PubMed ID: 3066996
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for drugs in forensic blood samples using EMIT urine assays.
    Gjerde H; Christophersen AS; Skuterud B; Klemetsen K; Mørland J
    Forensic Sci Int; 1990 Feb; 44(2-3):179-85. PubMed ID: 2180797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassay method validation for a modified EMIT phencyclidine assay.
    Cary PL; Johnson CA; Folsom TM; Bales WR
    J Anal Toxicol; 1992; 16(1):48-51. PubMed ID: 1640698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
    Pearson SD; Ash KO; Urry FM
    Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of phencyclidine by EMIT d.a.u. utilizing the ETS analyzer and a 25-ng/mL cutoff.
    Sneath TC; Jain NC
    J Anal Toxicol; 1992; 16(2):107-8. PubMed ID: 1501457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening with EMIT reagents: a quantitative approach to quality control.
    Standefer JC; Backer RC
    Clin Chem; 1991 May; 37(5):733-8. PubMed ID: 2032329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Emit II reagents on the Chem 1.
    Sreenivasam RC; Sneath TC; Jain NC
    J Anal Toxicol; 1993 Oct; 17(6):370-3. PubMed ID: 8271784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cannabinoid analysis: comparison of four immunoassays with gas chromatography-mass spectrometry.
    Altunkaya D; Clatworthy AJ; Smith RN; Start IJ
    Forensic Sci Int; 1991; 50(1):15-22. PubMed ID: 1937304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxylamine: a cause for false-positive gas chromatographic assay for phencyclidine.
    Schaldenbrand JD; McClatchey KD; Patel JA; Muilenberg MJ
    Ther Drug Monit; 1981; 3(2):181-3. PubMed ID: 7022772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of clinical toxicology urine specimens using the KDI Quik test.
    Kaplan RM; Fochtman F; Brunett P; White C; Heller MB
    J Toxicol Clin Toxicol; 1989; 27(6):369-73. PubMed ID: 2697762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays.
    Asselin WM; Leslie JM; McKinley B
    J Anal Toxicol; 1988; 12(4):207-15. PubMed ID: 3054319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for amphetamines, barbiturates, methadone, methaqualone, phencyclidine, and propoxyphene.
    Klinger RA; Blum LM; Rieders F
    J Anal Toxicol; 1990; 14(5):288-91. PubMed ID: 2263063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of phencyclidine in urine by enzyme immunoassay.
    Walberg CB; Gupta RC
    J Anal Toxicol; 1982; 6(2):97-9. PubMed ID: 7047902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.